Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
19.01B | 17.77B | 7.61B | 3.82B | 15.98B | Gross Profit |
5.96B | 3.03B | -198.60M | -1.51B | 1.20B | EBIT |
2.73B | 1.65B | -867.80M | -2.14B | 295.50M | EBITDA |
5.62B | 5.17B | 1.42B | -2.43B | 2.27B | Net Income Common Stockholders |
2.67B | 2.16B | -962.00M | -4.27B | -212.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
12.66B | 16.73B | 14.17B | 8.05B | 3.11B | Total Assets |
44.26B | 50.19B | 49.72B | 37.58B | 33.71B | Total Debt |
13.45B | 15.34B | 15.92B | 14.34B | 11.78B | Net Debt |
2.18B | -988.30M | 2.15B | 6.55B | 9.10B | Total Liabilities |
27.52B | 29.94B | 26.92B | 21.30B | 23.98B | Stockholders Equity |
16.34B | 19.86B | 22.41B | 15.91B | 9.31B |
Cash Flow | Free Cash Flow | |||
3.73B | 7.47B | -289.20M | -6.21B | -2.54B | Operating Cash Flow |
5.05B | 9.15B | 2.83B | -3.44B | 2.66B | Investing Cash Flow |
-1.44B | -490.10M | -2.32B | -1.40B | -5.10B | Financing Cash Flow |
-8.78B | -5.88B | 5.44B | 9.97B | 2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $33.74B | 9.16 | 27.52% | 1.22% | 4.91% | -27.21% | |
79 Outperform | $27.17B | 7.17 | 33.57% | ― | 5.31% | 35.95% | |
74 Outperform | $30.07B | 18.28 | 22.41% | 1.61% | 5.39% | -15.92% | |
68 Neutral | $16.41B | 8.27 | 17.47% | 5.44% | 5.35% | -25.52% | |
68 Neutral | $19.58B | 40.80 | 5.63% | 2.15% | 3.26% | 27.77% | |
66 Neutral | $4.52B | 12.34 | 5.41% | 3.62% | 4.15% | -12.18% | |
61 Neutral | $7.81B | 12.77 | -21.27% | ― | 1.92% | 36.07% |